Anticaries and Antigingivitis Properties of Cannabinoid-Containing Oral Health Products: A Review
- 1 October 2024
- journal article
- research article
- Published by SAGE Publications in Cannabis & Cannabinoid Research
- Vol. 9 (5) , e1377-e1384
Abstract
To evaluate the anticaries and antigingivitis properties of cannabinoid-containing oral health products. A systematic research strategy was employed. Specific search terms were used, including “Cannabinoids AND dental caries,” “Cannabinoids AND oral health,” “Cannabinoids AND dental plaque,” “Cannabinoids AND gingivitis AND periodontitis,” “Cannabinoids AND S. mutans,” “Cannabidiol AND oral health,” and “Cannabidiol AND oral biofilm.” The search was conducted in PubMed, Cochrane, and EBSCO Host databases. The search yielded a total of 73 articles, out of which 15 articles (20.5%) were relevant to the scope of this systematic review. Among the relevant articles, only eight (10.9%) directly addressed the research question. The findings from these articles suggest that cannabinoids have the potential to reduce the metabolism of cariogenic bacteria, specifically Streptococcus mutans , and decrease the number of bacterial colonies in dental plaque. In vitro studies also demonstrated a significant inhibitory effect of cannabinoids on oral biofilms and create a considerable inhibitory zone of growth when investigated on oral biofilms in vitro . Furthermore, CBD exhibited antibacterial properties against Porphyromonas gingivalis , a primary pathogen associated with periodontal disease. The current review shows insufficient data to conclude on the anticaries and antigingivitis effects of cannabinoids. Despite extensive research on their systemic therapeutic benefits, their oral health impact remains underexplored, lacking clinical trials and primary research.Keywords
This publication has 27 references indexed in Scilit:
- A critical review of cannabis in medicine and dentistry: A look back and the path forwardClinical and Experimental Dental Research, 2022
- Microbial dysbiosis: The root cause of periodontal diseaseJournal of Periodontology, 2021
- The antimicrobial effect behind Cannabis sativaPharmacology Research & Perspectives, 2021
- Review of the Endocannabinoid SystemBiological Psychiatry: Cognitive Neuroscience and Neuroimaging, 2020
- Oral diseases: a global public health challengeThe Lancet, 2019
- Effects of cannabidiol, a Cannabis sativa constituent, on oral wound healing process in rats: Clinical and histological evaluationPhytotherapy Research, 2018
- The pharmacokinetics and the pharmacodynamics of cannabinoidsBritish Journal of Clinical Pharmacology, 2018
- An Introduction to the Endogenous Cannabinoid SystemBiological Psychiatry, 2016
- Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF‐κB pathway inhibitionFEBS Letters, 2006
- The endocannabinoid system and its therapeutic exploitationNature Reviews Drug Discovery, 2004